The association between CHA2DS2-VASc score and aortic valve sclerosis.
Cardiovasc J Afr
; 34: 1-6, 2023 Jul 26.
Article
de En
| MEDLINE
| ID: mdl-37526976
ABSTRACT
BACKGROUND:
Antithrombotic therapy in atrial fibrillation is generally managed with the CHA2DS2-VASc score. Aortic valve sclerosis (AVS) is a focal thickening of the aortic valve without a restriction of motion. AVS is related to several cardiovascular risk factors. Our study was performed to evaluate whether the presence of AVS was associated with the CHA2DS2-VASc score.METHODS:
This cross-sectional, observational study comprised 411 patients with AVS grades 1-3 [AVS (+)] and 102 patients with AVS grade 0 [AVS (-)]. We compared CHA2DS2-VASc scores between the AVS (+) and AVS (-) groups.RESULTS:
We determined that the AVS (+) group had a higher CHA2DS2-VASc score than the AVS (-) group [3 (0-8) vs 1 (0-4), p < 0.001) ].CONCLUSIONS:
In our study, the CHA2DS2-VASc score was found to be higher in patients with AVS than in those without AVS. AVS may predict cardiovascular risk in the general population.
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Langue:
En
Journal:
Cardiovasc J Afr
Sujet du journal:
ANGIOLOGIA
/
CARDIOLOGIA
Année:
2023
Type de document:
Article